By Vandana Singh Pfizer Inc (NYSE: PFE) cautions about potential supply shortages for pediatric Bicillin L-A, an antibiotic for syphilis treatment, by the end of June. The company has prioritized the production of adult versions due to a surge in syphilis infections in that population. NEW YORK, NEW YORK – APRIL 10: The Pfizer company logo is displayed as traders work […]
The post Pfizer Warns Of Potential Pediatric Antibiotic Shortage Amid Surge In Syphilis Infections first appeared on The Florida Star | The Georgia Star.